Cargando…

Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial

BACKGROUND: Pharmaceutical care is the direct interaction between pharmacist and patient, in order to improve therapeutic compliance, promote adequate pharmacotherapeutic follow-up, and improve quality of life. Pharmaceutical care may be effective in reducing complications and in improving the quali...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Gilberto M Sperandio, Chambela, Mayara C, Sousa, Andrea S, Sangenis, Luiz Henrique C, Xavier, Sergio S, Costa, Andréa R, Brasil, Pedro Emmanuel AA, Hasslocher-Moreno, Alejandro M, Saraiva, Roberto M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543334/ https://www.ncbi.nlm.nih.gov/pubmed/23270509 http://dx.doi.org/10.1186/1745-6215-13-244

Ejemplares similares

Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease
por: Saraiva, Roberto M., et al.
Publicado: (2022)

FIRST REPORT OF ACUTE CHAGAS DISEASE BY VECTOR TRANSMISSION IN RIO DE JANEIRO STATE, BRAZIL
por: SANGENIS, Luiz Henrique Conde, et al.
Publicado: (2015)

Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care
por: Saraiva, Roberto M, et al.
Publicado: (2021)

Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study
por: Hasslocher-Moreno, Alejandro M., et al.
Publicado: (2020)

Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro
por: Vizzoni, Alexandre Gomes, et al.
Publicado: (2018)

Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2020)

Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2021)

ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis
por: Brasil, Pedro EAA, et al.
Publicado: (2010)

Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease
por: Curvo, Eduardo OV, et al.
Publicado: (2018)

Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2021)

Letters to the Editor: Indeterminate form of Chagas Disease: some immunological insights
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
por: Silva, Paula Simplício da, et al.
Publicado: (2017)

Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease
por: Xavier, Isis Gabrielli Gomes, et al.
Publicado: (2021)

Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trial
por: Mediano, Mauro F. F., et al.
Publicado: (2023)

The association of exercise test variables with long-term mortality in patients with chronic Chagas disease
por: Silva, Rudson S., et al.
Publicado: (2022)

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2020)

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease
por: Mendes, Veronica G., et al.
Publicado: (2023)

Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas’ Myocarditis
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2017)

The association between variables of cardiopulmonary exercise test and quality of life in patients with chronic Chagas cardiomyopathy (Insights from the PEACH STUDY)
por: Vieira, Marcelo Carvalho, et al.
Publicado: (2022)

Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized Trial
por: Holanda, Marcelo T., et al.
Publicado: (2021)

Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients
por: Sperandio da Silva, Gilberto Marcelo, et al.
Publicado: (2022)

Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study)
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2016)

Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients
por: Sperandio da Silva, Gilberto Marcelo, et al.
Publicado: (2022)

Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil
por: Nielebock, Marco Antonio Prates, et al.
Publicado: (2020)

Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial
por: Silva, Paula S, et al.
Publicado: (2013)

Adverse drug events and the associated factors in patients with chronic Chagas disease
por: Lopes, Luiza Braz da Cunha, et al.
Publicado: (2020)

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
por: Rodrigues-dos-Santos, Ícaro, et al.
Publicado: (2018)

Re: “Immunothrombotic dysregulation in chagas disease and COVID‑19: a comparative study of anticoagulation”
por: Hasslocher-Moreno, Alejandro Marcel
Publicado: (2022)

Re: “Challenges of addressing neglected tropical diseases amidst the COVID-19 pandemic in Africa: A case of Chagas Disease”
por: Hasslocher-Moreno, Alejandro Marcel
Publicado: (2022)

The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity
por: Georg, Ingebourg, et al.
Publicado: (2017)

TGF-β Polymorphisms Are a Risk Factor for Chagas Disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2018)

Autochthonous transmission of Chagas disease in Rio de Janeiro State, Brazil: a clinical and eco-epidemiological study
por: Sangenis, Luiz Henrique Conde, et al.
Publicado: (2015)

Comprehensive care for patients with Chagas cardiomyopathy during the coronavirus disease pandemic
por: Mazzoli-Rocha, Flavia, et al.
Publicado: (2020)

Traditional use of benznidazole with weekly clinical follow-up indicate to be an important approach for the etiologic treatment of Chagas disease
por: Sperandio da Silva, Gilberto Marcelo
Publicado: (2022)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease
por: Araujo-Jorge, Tania C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_171gkee4t8krqc0vvdb72cga1i